PER 0.00% 8.1¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-29

  1. 11,063 Posts.
    lightbulb Created with Sketch. 993
    Personal attacks? For real? It's me in denial and not you?
    Anyhow, your comments are totally and absolutely incorrect kp. I'm beginning to believe that should ANP earn wads of cash in the future ,that you wouldn't enjoy it. Personally I'd like to see every shareholders make a fortune. The dice are rolling and we are well funded. What's not to like?

    I see hope where you see grim failure. I know that they could fail totally. I also know that they could succeed spectacularly, ie, a balanced view. Time and not personal insults will tell. Have a good life kp and keep your chin up. It may not happen. But then again it just may....

    Good luck all holders of ANP, the light at the end of the tunnel may not be a train after all.
    Oh, do I detect a faint whiff of that wonderful sweet smell of success?
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
0.000(0.00%)
Mkt cap ! $83.97M
Open High Low Value Volume
8.0¢ 8.1¢ 8.0¢ $61.91K 766.3K

Buyers (Bids)

No. Vol. Price($)
4 549730 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 94626 1
View Market Depth
Last trade - 15.59pm 31/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.